Oseltamivir phosphate ndi mankhwala oletsa tizilombo toyambitsa matenda omwe amagwiritsidwa ntchito pochiza matenda owopsa a chimfine mwa akulu, achinyamata ndi ana (≥2 milungu yakubadwa). Oselavir® idzapezeka ku China mu mawonekedwe a mlingo - 12.5ml: 75mg ufa wa kuyimitsidwa pakamwa.
WHO ikuyerekeza kuti chimfine cha nyengo chikhoza kupha 290,000-650,000 chaka chilichonse chifukwa cha matenda opuma okha. Kuyerekezaku sikumaganizira za imfa za matenda ena monga matenda amtima, omwe angakhale okhudzana ndi chimfine1.
Dr. Vamsi Krishna Bandi, Managing Director, Hetero Group of Companies adati, "Ndife okondwa kuti Hetero mogwirizana ndi Shenzhen Beimei Pharmaceuticals, China, adalandira chilolezo cha Oselavir® (Oseltamivir) ku China. Ichi ndi chivomerezo choyamba cha Hetero ku China, ndipo tadzipereka kubweretsa zinthu zambiri ku China posachedwa. "
Mayi Guangmei Wu, Purezidenti ndi CEO wa Shenzhen Beimei Pharmaceuticals adati, "Ndi kukhulupirirana komanso kuthandizirana pakati pa magulu a Beimei ndi Hetero, Oselavir® idakhazikitsidwa ku China ngati mankhwala oyamba a Oseltamivir ku China omwe adavomereza mumkhalidwe wokhudzana ndi ana. Ndikuthokoza gulu la Hetero chifukwa chogwira ntchito molimbika komanso khama pantchito yonse yopangira zinthu, kulembetsa kulembetsa ndikukonzekera kukhazikitsa Oselavir®. Tikuyembekezera kuwona zinthu zambiri ndi Hetero pazachipatala chapadziko lonse lapansi m'tsogolomu. "
ZOMWE MUNGACHITE PA NKHANIYI:
- This is the first finished product approval for Hetero in China, and we are committed to bring more products to China in the near future.
- Ndikuthokoza gulu la Hetero chifukwa chogwira ntchito molimbika komanso khama pantchito yonse yopangira zinthu, kulembetsa kulembetsa ndikukonzekera kukhazikitsa Oselavir®.
- Guangmei Wu, President and CEO of Shenzhen Beimei Pharmaceuticals said, “With mutual trust and support between Beimei and Hetero teams, Oselavir® was launched in China as the first Chinese approved Oseltamivir product in paediatric-specific dosage form.
